|
Asthma Therapeutics in Asia-Pacific Markets to 2021 – Launch of Late-Stage Biologics will Drive the Market in Spite …
Business Wire (press release) Over the 2015-2021 forecast period, the asthma therapeutics market in the Asia-Pacific region is expected to increase in value at a Compound Annual Growth Rate (CAGR) of 7.2%, from $3.5 billion to over $5.6 billion. Analysis of clinical trials since … |
View full post on asthma – Google News